DGTR advances anti-dumping investigation into tuberculosis drug imports from China, Thailand

The Directorate General of Trade Remedies (DGTR) has advanced an anti-dumping investigation into imports from China and Thailand of Ethambutol Hydrochloride, an active pharmaceutical ingredient used in anti-tuberculosis drugs, by releasing a list of registered interested parties. The investigation comes as India ramps up efforts to counter unfair trade practices that disadvantage domestic industries. The trade remedies body issued 15 final findings of such practices in September across sectors ranging from glass fibre and steel to solar cells and chemical products. The DGTR, in a statement, named Chinese producer Wuhan Wuyao Pharmaceuticals Co. Ltd among the foreign respondents. It said there was evidence of dumping and injury, with imports undercutting domestic prices. The probe will cover the period April 2024-March 2025, and may result in anti-dumping duties if the findings confirm injury to the Indian industry, as per a report.

Please visit our youtube channel https://www.youtube.com/@ikargos2719 for fortnightly logistics news analysis and more!